psychedelics

Ignite It
3 min read • September 20, 2024

Was Cannabis The Secret To Jesus’ Healing Miracles? Study Uncovers Ancient Remedies

Ignite It
3 min read • September 20, 2024

Is Cannabis Legalization Reducing Psychiatric Drug Use? Study Reveals Interesting Trends In Benzodiazepine, Antidepressants, Antipsychotics

Ignite It
2 min read • September 19, 2024

Alabama Marijuana Company Sues Medical Cannabis Commission Over Licensing Chaos, Seeks Program Overhaul As Patients Remain In Limbo

Ignite It
3 min read • September 17, 2024

DEA Endorses New, Simplified Test To Determine Marijuana’s Medical Uses Amid Rescheduling Debate: Could It Also Apply To Psychedelics?

Ignite It
3 min read • September 16, 2024

Norwalk, CT’s First Cannabis Dispensary Faces Solar Panel Dilemma: Tree Shade And Low ROI Hinder Compliance

Ignite It
3 min read • September 16, 2024

Nebraska Medical Cannabis Legalization Heads Into November Election Amid Signature Controversy

Ignite It
2 min read • September 13, 2024

Marijuana Sales Hit Record Highs In These 6 US States: Is Marijuana Outpacing Alcohol?

Ignite It
4 min read • September 9, 2024

Cannabis Use Rose Among US Adults Over 10 Years, But Kept Steady In Teens, Finds New Study

Ignite It
5 min read • September 6, 2024

Leadership Shake-Ups In Cannabis And Psychedelics: Maryland’s Cannabis Chief Resigns, Costly Legal Battle In MA Drags On & More

Ignite It
4 min read • August 30, 2024

Cannabis And Hallucinogen Consumption Hit All Time Highs In 2023 While Tobacco And Alcohol Declined

Ignite It
3 min read • August 29, 2024

60 Years Ago, Bob Dylan Turned The Beatles On To Cannabis, Transforming Them And Rock Culture Forever

Ignite It
5 min read • August 28, 2024

Cannabis And Psychedelics Industries: Summer’s Over, Where Are We?

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis earnings
 cannabis farms
 cannabis study
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 Hot
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.